BioForm Financial Statements
BioForm Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | June |
This data is provided as per license from EDGAR Online
BioForm Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 47.4 | 22.6 | 16.2 |
| Gross Profit ($ mil.) | 38.6 | 18.4 | 13.3 |
| Operating Income ($ mil.) | (14.3) | (11.6) | (10.9) |
| Total Net Income ($ mil.) | (13.6) | (11.4) | (10.7) |
| Diluted EPS (Net Income) | (3.54) | (3.96) | -- |
BioForm Stock Quote & Chart
08/29/08 15:00:06 EST •
NASDAQ •
3.98
•
 -1.2500
•
-23.9006 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
BioForm Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 4.98 | 2.19 | 1.56 |
| Price/Earnings Ratio | -- | 22.29 | 15.82 |
| Price/Book Ratio | 9.20 | 2.28 | 1.52 |
| Price/Cash Flow Ratio | -- | 15.76 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed BioForm Financial Ratios
BioForm Competitive Intelligence
| Allergan Limited | Johnson & Johnson | Medicis Pharmaceutical | |
|---|---|---|---|
| Annual Sales ($ mil.) | 38.5 | 61,095.0 | 464.6 |
| Employees | 209 | -- | 472 |
| Market Cap ($ mil.) | -- | 199,077.4 | 1,442.4 |
Competitive Landscape
